Toyoda H - Search Results

1

Prognosis of biopsy-confirmed metabolic dysfunction- associated steatotic liver disease: A sub-analysis of the CLIONE study.

Iwaki M, Fujii H, Hayashi H, Toyoda H, Oeda S, Hyogo H, Kawanaka M, Morishita A, Munekage K, Kawata K, Tsutsumi T, Sawada K, Maeshiro T, Tobita H, Yoshida Y, Naito M, Araki A, Arakaki S, Kawaguchi T, Noritake H, Ono M, Masaki T, Yasuda S, Tomita E, Yoneda M, Tokushige A, Kamada Y, Takahashi H, Ueda S, Aishima S, Sumida Y, Nakajima A, Okanoue T. Iwaki M, et al. Among authors: toyoda h. Clin Mol Hepatol. 2024 Apr;30(2):225-234. doi: 10.3350/cmh.2023.0515. Epub 2024 Jan 24. Clin Mol Hepatol. 2024. PMID: 38263684 Free PMC article.

2

Impact of hepatitis B virus (HBV) X gene integration in liver tissue on hepatocellular carcinoma development in serologically HBV-negative chronic hepatitis C patients.

Toyoda H, Kumada T, Kaneoka Y, Murakami Y. Toyoda H, et al. J Hepatol. 2008 Jan;48(1):43-50. doi: 10.1016/j.jhep.2007.08.016. Epub 2007 Oct 24. J Hepatol. 2008. PMID: 18023912

3

Effect of nucleos(t)ide analogue therapy on hepatocarcinogenesis in chronic hepatitis B patients: a propensity score analysis.

Kumada T, Toyoda H, Tada T, Kiriyama S, Tanikawa M, Hisanaga Y, Kanamori A, Niinomi T, Yasuda S, Andou Y, Yamamoto K, Tanaka J. Kumada T, et al. Among authors: toyoda h. J Hepatol. 2013 Mar;58(3):427-33. doi: 10.1016/j.jhep.2012.10.025. Epub 2012 Oct 30. J Hepatol. 2013. PMID: 23123221

4

Geographic distribution and characteristics of genotype A hepatitis B virus infection in acute and chronic hepatitis B patients in Japan.

Ito K, Yotsuyanagi H, Sugiyama M, Yatsuhashi H, Karino Y, Takikawa Y, Saito T, Arase Y, Imazeki F, Kurosaki M, Umemura T, Ichida T, Toyoda H, Yoneda M, Tanaka Y, Mita E, Yamamoto K, Michitaka K, Maeshiro T, Tanuma J, Korenaga M, Murata K, Masaki N, Koike K, Mizokami M; Japanese AHB CHB Study Group. Ito K, et al. Among authors: toyoda h. J Gastroenterol Hepatol. 2016 Jan;31(1):180-9. doi: 10.1111/jgh.13030. J Gastroenterol Hepatol. 2016. PMID: 26110395

5

Liver fibrosis indices for identifying patients at low risk of developing hepatocellular carcinoma after eradication of HCV.

Toyoda H, Tada T, Tachi Y, Hirai T, Yasuda S, Honda T, Hayashi K, Ishigami M, Goto H, Kumada T. Toyoda H, et al. Antivir Ther. 2017;22(3):185-193. doi: 10.3851/IMP3081. Epub 2016 Sep 2. Antivir Ther. 2017. PMID: 27586087

6

Efficacy and tolerability of an IFN-free regimen with DCV/ASV for elderly patients infected with HCV genotype 1B.

Toyoda H, Kumada T, Tada T, Shimada N, Takaguchi K, Senoh T, Tsuji K, Tachi Y, Hiraoka A, Ishikawa T, Shima T, Okanoue T. Toyoda H, et al. J Hepatol. 2017 Mar;66(3):521-527. doi: 10.1016/j.jhep.2016.11.012. Epub 2016 Nov 25. J Hepatol. 2017. PMID: 27890790 Clinical Trial.

7

Ability of Cytokeratin-18 Fragments and FIB-4 Index to Diagnose Overall and Mild Fibrosis Nonalcoholic Steatohepatitis in Japanese Nonalcoholic Fatty Liver Disease Patients.

Kobayashi N, Kumada T, Toyoda H, Tada T, Ito T, Kage M, Okanoue T, Kudo M. Kobayashi N, et al. Among authors: toyoda h. Dig Dis. 2017;35(6):521-530. doi: 10.1159/000480142. Epub 2017 Oct 17. Dig Dis. 2017. PMID: 29040984

8

New scoring system combining the FIB-4 index and cytokeratin-18 fragments for predicting steatohepatitis and liver fibrosis in patients with nonalcoholic fatty liver disease.

Tada T, Kumada T, Toyoda H, Saibara T, Ono M, Kage M. Tada T, et al. Among authors: toyoda h. Biomarkers. 2018 May-Jun;23(4):328-334. doi: 10.1080/1354750X.2018.1425915. Epub 2018 Jan 19. Biomarkers. 2018. PMID: 29308929

9

Substitutions in interferon sensitivity-determining region and hepatocarcinogenesis after hepatitis C virus eradication.

Yasuda S, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Hayashi K, Toyoda H, Kumada T, Hirooka Y, Goto H. Yasuda S, et al. Among authors: toyoda h. J Gastroenterol Hepatol. 2018 Nov;33(11):1904-1911. doi: 10.1111/jgh.14280. Epub 2018 Jun 3. J Gastroenterol Hepatol. 2018. PMID: 29744922

10

Utility and limitations of noninvasive fibrosis markers for predicting prognosis in biopsy-proven Japanese non-alcoholic fatty liver disease patients.

Ito T, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Hayashi K, Nishimura D, Toyoda H, Kumada T, Goto H, Hirooka Y. Ito T, et al. Among authors: toyoda h. J Gastroenterol Hepatol. 2019 Jan;34(1):207-214. doi: 10.1111/jgh.14448. Epub 2018 Sep 18. J Gastroenterol Hepatol. 2019. PMID: 30144360

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,490 results

Search Page

Filters